Pharmaceuticals, Biotechnology and Life Sciences
ALG-1007 Marks Allegro’s Second Exploratory Anti-Integrin Drug Candidate—Now, for the Potential Treatment of Dry Eye Disease SAN JUAN CAPISTRANO, Calif.–(BUSINESS…
ReGenTree and Ora will mutually start testing the ReGenTree’s new drug RGN-259 for the treatment of dry eye syndrome, in a clinical study named ARISE-3, based entirely on the results of a previous clinical trials, ARISE-1 and ARISE-2.
Alergan will have to cut over 1000 jobs from commercial and other functions, the company said on Wednesday.
HanAll Biopharma and Harbour BioMed on Tuesday announced agreeing to produce and sell HanAll’s two novel biologics, in Greater China, including Hong Kong, Macau and Taiwan,…
Novartis said Thursday it has exercised an option to in-license ECF843 for ophthalmic indications worldwide excepot of Europe, without revealing financial and other terms of this transaction.